These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38700304)

  • 1. Comparison of Guillain-Barre Syndrome Cases during and Prior to the COVID-19 Pandemic: A Multicentric Study.
    Panicker P; R D; Gafoor AV; R PS; Iype T; Jose J; Stanley A
    J Assoc Physicians India; 2023 Sep; 71(9):69-71. PubMed ID: 38700304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.
    Luijten LWG; Leonhard SE; van der Eijk AA; Doets AY; Appeltshauser L; Arends S; Attarian S; Benedetti L; Briani C; Casasnovas C; Castellani F; Dardiotis E; Echaniz-Laguna A; Garssen MPJ; Harbo T; Huizinga R; Humm AM; Jellema K; van der Kooi AJ; Kuitwaard K; Kuntzer T; Kusunoki S; Lascano AM; Martinez-Hernandez E; Rinaldi S; Samijn JPA; Scheidegger O; Tsouni P; Vicino A; Visser LH; Walgaard C; Wang Y; Wirtz PW; Ripellino P; Jacobs BC;
    Brain; 2021 Dec; 144(11):3392-3404. PubMed ID: 34553216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.
    Keddie S; Pakpoor J; Mousele C; Pipis M; Machado PM; Foster M; Record CJ; Keh RYS; Fehmi J; Paterson RW; Bharambe V; Clayton LM; Allen C; Price O; Wall J; Kiss-Csenki A; Rathnasabapathi DP; Geraldes R; Yermakova T; King-Robson J; Zosmer M; Rajakulendran S; Sumaria S; Farmer SF; Nortley R; Marshall CR; Newman EJ; Nirmalananthan N; Kumar G; Pinto AA; Holt J; Lavin TM; Brennan KM; Zandi MS; Jayaseelan DL; Pritchard J; Hadden RDM; Manji H; Willison HJ; Rinaldi S; Carr AS; Lunn MP
    Brain; 2021 Mar; 144(2):682-693. PubMed ID: 33313649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up.
    Ahmad L; Businaro P; Regalbuto S; Gastaldi M; Zardini E; Panzeri M; Vegezzi E; Fiamingo G; Colombo E; Ravaglia S
    Medicine (Baltimore); 2022 Jul; 101(30):e29704. PubMed ID: 35905215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased Incidence of Guillain-Barré Syndrome during the COVID-19 Pandemic: A Retrospective Population-Based Study.
    Hafsteinsdóttir B; Dalemo E; Elíasdóttir Ó; Ólafsson E; Axelsson M
    Neuroepidemiology; 2023; 57(1):1-6. PubMed ID: 36366822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the 'Italian factor'.
    Censi S; Bisaccia G; Gallina S; Tomassini V; Uncini A
    Eur J Neurol; 2024 Feb; 31(2):e16094. PubMed ID: 37823707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barre syndrome before and during the COVID-19 pandemic in a referral center of Mexico.
    López-Hernández JC; Vargas-Cañas ES; Estrada SA; Galnares-Olalde J
    Gac Med Mex; 2023; 159(4):315-321. PubMed ID: 37699231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two case reports and a literature review of typical GBS and rare GBS variants associated with COVID-19.
    Orak SA; Kubur ÇÇ; Atasever AK; Polat M
    Arch Pediatr; 2023 May; 30(4):236-239. PubMed ID: 37069023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 infection presented as Guillain-Barre Syndrome: Report of two new cases and review of 116 reported cases and case series.
    Elzouki AN; Osman MAM; Ahmed MAE; Al-Abdulmalek A; Altermanini M; Al-Ani HA; Naeem M; Habas E
    Travel Med Infect Dis; 2021; 44():102169. PubMed ID: 34624553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.
    Abu-Rumeileh S; Abdelhak A; Foschi M; Tumani H; Otto M
    J Neurol; 2021 Apr; 268(4):1133-1170. PubMed ID: 32840686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study.
    Filosto M; Cotti Piccinelli S; Gazzina S; Foresti C; Frigeni B; Servalli MC; Sessa M; Cosentino G; Marchioni E; Ravaglia S; Briani C; Castellani F; Zara G; Bianchi F; Del Carro U; Fazio R; Filippi M; Magni E; Natalini G; Palmerini F; Perotti AM; Bellomo A; Osio M; Nascimbene C; Carpo M; Rasera A; Squintani G; Doneddu PE; Bertasi V; Cotelli MS; Bertolasi L; Fabrizi GM; Ferrari S; Ranieri F; Caprioli F; Grappa E; Manganotti P; Bellavita G; Furlanis G; De Maria G; Leggio U; Poli L; Rasulo F; Latronico N; Nobile-Orazio E; Beghi E; Padovani A; Uncini A
    Eur J Neurol; 2022 Nov; 29(11):3358-3367. PubMed ID: 35837806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.
    Caress JB; Castoro RJ; Simmons Z; Scelsa SN; Lewis RA; Ahlawat A; Narayanaswami P
    Muscle Nerve; 2020 Oct; 62(4):485-491. PubMed ID: 32678460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant Guillain-Barré Syndrome and COVID-19: A Meta-Analysis of Cases.
    Bentley SA; Ahmad S; Kobeissy FH; Toklu HZ
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557036
    [No Abstract]   [Full Text] [Related]  

  • 14. Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study.
    Bishara H; Arbel A; Barnett-Griness O; Bloch S; Cohen S; Najjar-Debbiny R; Gronich N; Auriel E; Saliba W
    Neurology; 2023 Nov; 101(20):e2035-e2042. PubMed ID: 37852786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy).
    Martinelli-Boneschi F; Colombo A; Bresolin N; Sessa M; Bassi P; Grampa G; Magni E; Versino M; Ferrarese C; Zarcone D; Albanese A; Micieli G; Zanferrari C; Cagnana A; Ferrante C; Zilioli A; Locatelli D; Calloni MV; Delodovici ML; Pozzato M; Patisso V; Bortolan F; Foresti C; Frigeni B; Canella S; Xhani R; Crabbio M; Clemenzi A; Mauri M; Beretta S; La Spina I; Bernasconi S; De Santis T; Cavallini A; Ranieri M; D'Adda E; Fruguglietti ME; Peverelli L; Agosti E; Leoni O; Rigamonti A; Salmaggi A
    Neurol Sci; 2023 Feb; 44(2):437-446. PubMed ID: 36289117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barre syndrome in Mexico: clinical features and validation of Brighton Collaboration Group criteria.
    López-Hernández JC; Galnares-Olalde JA; Gutiérrez A; Estrada SA; García-Grimshaw M; Vargas-Cañas ES
    Rev Neurol; 2022 Apr; 74(8):258-264. PubMed ID: 35383873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy.
    Garnero M; Del Sette M; Assini A; Beronio A; Capello E; Cabona C; Reni L; Serrati C; Bandini F; Granata A; Pesce G; Mancardi GL; Uccelli A; Schenone A; Benedetti L
    J Neurol Sci; 2020 Nov; 418():117114. PubMed ID: 32947089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
    Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
    Front Immunol; 2021; 12():674922. PubMed ID: 34040615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?
    Zheng X; Fang Y; Song Y; Liu S; Liu K; Zhu J; Wu X
    Eur J Med Res; 2023 Feb; 28(1):98. PubMed ID: 36841799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A systematic review and individual participant data meta-analysis.
    Hasan I; Saif-Ur-Rahman KM; Hayat S; Papri N; Jahan I; Azam R; Ara G; Islam Z
    J Peripher Nerv Syst; 2020 Dec; 25(4):335-343. PubMed ID: 33112450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.